Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy

Preeclampsia (PE) is characterized by new onset hypertension in association with placental ischemia, reduced fetal weight, elevated soluble fms-like tyrosine kinase-1 (sFlt-1), and placental mitochondrial (mt) dysfunction and oxidative stress (ROS). Progesterone induced blocking factor (PIBF) is a p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Evangeline Deer, Jalisa Jones, Denise C. Cornelius, Kyleigh Comley, Owen Herrock, Nathan Campbell, Sarah Fitzgerald, Tarek Ibrahim, Babbette LaMarca, Lorena M. Amaral
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/2dd90e6416b74dd1a0a18ea6cb2c6f3e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2dd90e6416b74dd1a0a18ea6cb2c6f3e
record_format dspace
spelling oai:doaj.org-article:2dd90e6416b74dd1a0a18ea6cb2c6f3e2021-11-25T17:07:31ZProgesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy10.3390/cells101128172073-4409https://doaj.org/article/2dd90e6416b74dd1a0a18ea6cb2c6f3e2021-10-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/2817https://doaj.org/toc/2073-4409Preeclampsia (PE) is characterized by new onset hypertension in association with placental ischemia, reduced fetal weight, elevated soluble fms-like tyrosine kinase-1 (sFlt-1), and placental mitochondrial (mt) dysfunction and oxidative stress (ROS). Progesterone induced blocking factor (PIBF) is a product of progesterone signaling that blocks inflammatory processes and we have previously shown PIBF to lower mean arterial blood pressure (MAP) and sFlt-1 in a rat model of PE. Infusion of sFlt-1 causes hypertension and many characteristics of PE in pregnant rodents, however, its role in causing mt dysfunction is unknown. Therefore, we hypothesize that PIBF will improve mt function and MAP in response to elevated sFlt-1 during pregnancy. We tested our hypothesis by infusing sFlt-1 via miniosmotic pumps in normal pregnant (NP) Sprague-Dawley rats (3.7 μg·kg<sup>−1</sup>·day<sup>−1</sup>) on gestation days (GD) 13–19 in the presence or absence of PIBF (2.0 µg/mL) injected intraperitoneally on GD 15 and examined mean arterial blood pressure (MAP) and placental mt ROS on GD 19. sFlt-1 increased MAP to 112 + 2 (n = 11) compared to NP rats (98 + 2 mmHg, n = 15, <i>p</i> < 0.05), which was lowered in the presence of sFlt-1 (100 + 1 mmHg, n = 5, <i>p</i> < 0.05). Placental mtATP was reduced in sFlt-1 infused rats versus NP controls, but was improved with PIBF. Placental mtROS was elevated with sFlt-1 compared to NP controls, but was reduced with PIBF. Sera from NP + sFlt-1 increased endothelial cell mtROS, which was attenuated with PIBF. These data demonstrate sFlt-1 induced HTN during pregnancy reduces placental mt function. Importantly, PIBF improved placental mt function and HTN, indicating the efficacy of improved progesterone signaling as potential therapeutics for PE.Evangeline DeerJalisa JonesDenise C. CorneliusKyleigh ComleyOwen HerrockNathan CampbellSarah FitzgeraldTarek IbrahimBabbette LaMarcaLorena M. AmaralMDPI AGarticlehypertensionpreeclampsiasFlt-1oxidative stressplacental ischemiaBiology (General)QH301-705.5ENCells, Vol 10, Iss 2817, p 2817 (2021)
institution DOAJ
collection DOAJ
language EN
topic hypertension
preeclampsia
sFlt-1
oxidative stress
placental ischemia
Biology (General)
QH301-705.5
spellingShingle hypertension
preeclampsia
sFlt-1
oxidative stress
placental ischemia
Biology (General)
QH301-705.5
Evangeline Deer
Jalisa Jones
Denise C. Cornelius
Kyleigh Comley
Owen Herrock
Nathan Campbell
Sarah Fitzgerald
Tarek Ibrahim
Babbette LaMarca
Lorena M. Amaral
Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy
description Preeclampsia (PE) is characterized by new onset hypertension in association with placental ischemia, reduced fetal weight, elevated soluble fms-like tyrosine kinase-1 (sFlt-1), and placental mitochondrial (mt) dysfunction and oxidative stress (ROS). Progesterone induced blocking factor (PIBF) is a product of progesterone signaling that blocks inflammatory processes and we have previously shown PIBF to lower mean arterial blood pressure (MAP) and sFlt-1 in a rat model of PE. Infusion of sFlt-1 causes hypertension and many characteristics of PE in pregnant rodents, however, its role in causing mt dysfunction is unknown. Therefore, we hypothesize that PIBF will improve mt function and MAP in response to elevated sFlt-1 during pregnancy. We tested our hypothesis by infusing sFlt-1 via miniosmotic pumps in normal pregnant (NP) Sprague-Dawley rats (3.7 μg·kg<sup>−1</sup>·day<sup>−1</sup>) on gestation days (GD) 13–19 in the presence or absence of PIBF (2.0 µg/mL) injected intraperitoneally on GD 15 and examined mean arterial blood pressure (MAP) and placental mt ROS on GD 19. sFlt-1 increased MAP to 112 + 2 (n = 11) compared to NP rats (98 + 2 mmHg, n = 15, <i>p</i> < 0.05), which was lowered in the presence of sFlt-1 (100 + 1 mmHg, n = 5, <i>p</i> < 0.05). Placental mtATP was reduced in sFlt-1 infused rats versus NP controls, but was improved with PIBF. Placental mtROS was elevated with sFlt-1 compared to NP controls, but was reduced with PIBF. Sera from NP + sFlt-1 increased endothelial cell mtROS, which was attenuated with PIBF. These data demonstrate sFlt-1 induced HTN during pregnancy reduces placental mt function. Importantly, PIBF improved placental mt function and HTN, indicating the efficacy of improved progesterone signaling as potential therapeutics for PE.
format article
author Evangeline Deer
Jalisa Jones
Denise C. Cornelius
Kyleigh Comley
Owen Herrock
Nathan Campbell
Sarah Fitzgerald
Tarek Ibrahim
Babbette LaMarca
Lorena M. Amaral
author_facet Evangeline Deer
Jalisa Jones
Denise C. Cornelius
Kyleigh Comley
Owen Herrock
Nathan Campbell
Sarah Fitzgerald
Tarek Ibrahim
Babbette LaMarca
Lorena M. Amaral
author_sort Evangeline Deer
title Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy
title_short Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy
title_full Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy
title_fullStr Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy
title_full_unstemmed Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy
title_sort progesterone induced blocking factor reduces hypertension and placental mitochondrial dysfunction in response to sflt-1 during pregnancy
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/2dd90e6416b74dd1a0a18ea6cb2c6f3e
work_keys_str_mv AT evangelinedeer progesteroneinducedblockingfactorreduceshypertensionandplacentalmitochondrialdysfunctioninresponsetosflt1duringpregnancy
AT jalisajones progesteroneinducedblockingfactorreduceshypertensionandplacentalmitochondrialdysfunctioninresponsetosflt1duringpregnancy
AT deniseccornelius progesteroneinducedblockingfactorreduceshypertensionandplacentalmitochondrialdysfunctioninresponsetosflt1duringpregnancy
AT kyleighcomley progesteroneinducedblockingfactorreduceshypertensionandplacentalmitochondrialdysfunctioninresponsetosflt1duringpregnancy
AT owenherrock progesteroneinducedblockingfactorreduceshypertensionandplacentalmitochondrialdysfunctioninresponsetosflt1duringpregnancy
AT nathancampbell progesteroneinducedblockingfactorreduceshypertensionandplacentalmitochondrialdysfunctioninresponsetosflt1duringpregnancy
AT sarahfitzgerald progesteroneinducedblockingfactorreduceshypertensionandplacentalmitochondrialdysfunctioninresponsetosflt1duringpregnancy
AT tarekibrahim progesteroneinducedblockingfactorreduceshypertensionandplacentalmitochondrialdysfunctioninresponsetosflt1duringpregnancy
AT babbettelamarca progesteroneinducedblockingfactorreduceshypertensionandplacentalmitochondrialdysfunctioninresponsetosflt1duringpregnancy
AT lorenamamaral progesteroneinducedblockingfactorreduceshypertensionandplacentalmitochondrialdysfunctioninresponsetosflt1duringpregnancy
_version_ 1718412704485474304